Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic and similar GLP-1 medications work by slowing stomach emptying and signaling fullness to the brain—effects achievable through both injection and oral delivery systems. Many patients seeking weight management ask whether they can avoid needles entirely, and the answer depends on which medication and formulation fits your goals and lifestyle. PlexusDx provides both routes with transparent pricing and personalized genetic insights.
How Oral Semaglutide Compares to Injectable Forms
Oral semaglutide is swallowed as a tablet, while injectable versions are administered under the skin once weekly. Both contain the same active ingredient and target the same GLP-1 receptors, but they differ in absorption rates and convenience. The oral form requires specific timing—taken on an empty stomach 30 minutes before food—whereas injections bypass the digestive system entirely. Clinical data shows oral semaglutide reaches peak blood levels within 1 hour, while injected forms provide steady hormone levels throughout the week.
PlexusDx offers compounded oral semaglutide starting at $249/month, giving patients a needle-free option without compromising efficacy. The choice between oral and injection often comes down to personal preference, meal consistency, and whether you respond equally well to both routes. Some patients find oral dosing easier to remember daily, while others prefer the weekly injection rhythm and potentially faster results.
Beyond Semaglutide: Other Non-Injectable Weight Loss Options
Tirzepatide represents a dual-action alternative that activates both GLP-1 and GIP receptors, potentially offering stronger appetite suppression than semaglutide alone. PlexusDx provides oral tirzepatide at $279/month, delivering the same dual-peptide benefit without injections. This medication was studied in trials showing greater weight loss compared to single-receptor agents, making it valuable for patients who need a more potent option.
For those wanting both peptides in one injection, PlexusDx also offers GLP-Squared Injection (semaglutide plus tirzepatide combined) starting at $249/month. The microdose GLP-1 protocol at $129/month serves as an entry point for patients new to peptide therapy. All formulations are compounded in licensed 503A pharmacies and available across all 50 states with no insurance requirement.
Understanding Compounded vs. Brand-Name Medications
Compounded semaglutide and tirzepatide are created in licensed 503A pharmacies under strict quality standards, offering the same active ingredients as brand medications but at significantly lower cost. These compounds are not FDA-approved as finished products, but the pharmacies themselves are licensed and regulated by state boards of pharmacy. PlexusDx partners exclusively with 503A compounders—never 503B manufacturers—ensuring personalized, small-batch preparation for each patient.
The cost difference is substantial: PlexusDx compounded semaglutide injection starts at $149/month versus thousands annually for brand Ozempic. No membership fees, no insurance needed, and HSA/FSA accounts are eligible. This pricing transparency means your dose may increase during treatment, but your monthly payment stays flat across all commitment tiers.
Genetic Testing to Find Your Best GLP-1 Match
Not every patient responds identically to semaglutide or tirzepatide. Genetic variations in GLP-1 receptors, GIP pathways, and metabolic regulators influence how effectively these drugs suppress appetite and promote weight loss in your body. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) that analyzes 14 pathways and 150+ genetic insights, including key variants like GLP1R rs6923761 and GIPR rs1800437.
This peptide-pathway testing (distinct from standard pharmacogenomic panels) reveals whether you're a responder to GLP-1 monotherapy, whether dual-peptide therapy like tirzepatide suits you better, or whether microdose protocols align with your genetic profile. Knowing these insights before committing to a specific medication reduces trial-and-error and accelerates your path to sustainable weight management.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is there a non-injectable version of Ozempic I can take?
Yes. Oral semaglutide tablets are available and contain the same active ingredient as Ozempic injections. PlexusDx offers compounded oral semaglutide starting at $249/month—a needle-free alternative with no insurance required and available in all 50 states.
What is the difference between oral and injectable GLP-1 medications?
Both oral and injectable forms target GLP-1 receptors and slow stomach emptying to reduce appetite. Injectable versions typically provide steadier hormone levels over a week, while oral formulations require empty-stomach timing but offer daily control. Clinical trials show comparable weight loss with both routes when used correctly.
How much does compounded semaglutide cost at PlexusDx?
Compounded semaglutide injection starts at $149/month, while oral semaglutide begins at $249/month. Your dose may increase during treatment, but your price remains flat across all commitment tiers—no surprise costs as you optimize your dose.
Are compounded medications from PlexusDx safe?
Yes. PlexusDx partners exclusively with licensed 503A compounding pharmacies that meet state regulatory standards. These pharmacies prepare personalized medications in small batches under quality oversight. While not FDA-approved as finished products, 503A compounds use FDA-approved active ingredients and are legal across all 50 states.
Can genetic testing help me choose between semaglutide and tirzepatide?
Absolutely. PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes variants in GLP-1, GIP, and metabolic genes to predict whether you'll respond best to single-receptor (semaglutide) or dual-receptor (tirzepatide) therapy. This test maps 14 pathways and 150+ insights to personalize your medication choice from day one.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Journey: Do You Have to Take Ozempic on an Empty Stomach?
Is Burping a Side Effect of Ozempic? Understanding the Digestive Impacts